Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002802951 | SCV003587555 | uncertain significance | Inborn genetic diseases | 2021-11-15 | criteria provided, single submitter | clinical testing | The c.485G>A (p.G162E) alteration is located in exon 3 (coding exon 3) of the KCNQ4 gene. This alteration results from a G to A substitution at nucleotide position 485, causing the glycine (G) at amino acid position 162 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003410173 | SCV004127873 | uncertain significance | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | KCNQ4: PM2, PP2, PP3 |
Genome- |
RCV003445218 | SCV004173131 | uncertain significance | Autosomal dominant nonsyndromic hearing loss 2A | 2023-04-11 | criteria provided, single submitter | clinical testing |